Pew Offers Strategies for Combatting Opioid Crisis to Senate Finance Committee

Recommendations focus on ways to expand access to high-quality treatment in Medicare and Medicaid

Pew Offers Strategies for Combatting Opioid Crisis to Senate Finance Committee

On Feb. 16, The Pew Charitable Trusts submitted comments on ways to address the opioid crisis to the U.S. Senate Committee on Finance, in response to calls for feedback from Committee Chairman Orrin Hatch and Ranking Member Ron Wyden. Pew’s comments recommend that legislators consider three issues when exploring ways to improve access to high-quality treatment in Medicare and Medicaid, including: 

  1. coverage of Food and Drug Administration-approved medications; 
  2. coverage of all of the American Society of Addiction Medicine’s levels of care; and 
  3. innovative treatment models. 
America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.